Australia well prepared for COVID-19 vaccine rollout

Australia is well placed for the rollout of a COVID-19 vaccine, once clinical trials and the regulator has confirmed safety and effectiveness. Under the Morrison Government’s COVID-19 Vaccine and Treatment Strategy, Australia has secured 134.8 million doses through advance purchasing agreements with four suppliers: AstraZeneca/Oxford, University of Queensland/CSL, Novavax and Pfizer/BioNTech. In addition, Australia has…

Australia secures a further 50 million doses of COVID-19 vaccine

Two more COVID-19 vaccines have been secured for the Australian population under new agreements, bringing the Australian Government’s COVID-19 vaccine investment to more than $3.2 billion. Under the agreements, Novavax will supply 40 million vaccine doses and Pfizer/BioNTech will provide 10 million vaccine doses, should the vaccines be proven safe and effective. Prime Minister Scott…